Category: Rheumatology/Arthritis
Global Rheumatology/Arthritis
-
Autoinjectors Market by Usage (Disposable, Reusable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Obesity, Anaphypaxis, Multiple Sclerosis), Route of Administration (SC, IM), Volume (<3ml, >3ml) - Global Forecast to 2030
... is projected to surge to a value of USD 134.27 billion in 2030 from USD 67.30 billion in 2024, growing at a CAGR of 12.2%. Favorable reimbursement policies in North America and Europe coupled with ... Read More
-
Generic Musculoskeletal Disorders Drugs Global Market Report 2025
... disorders drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Rheumatoid Arthritis Therapeutics
... at a CAGR of 4.1% over the analysis period 2024-2030. Pharmaceuticals, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$28.0 Billion by the end of the ... Read More
-
Rheumatoid Arthritis Diagnosis Tests
... reach US$1.0 Billion by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Serology Tests, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach ... Read More
-
Global Musculoskeletal Drugs Market 2024-2028
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Musculoskeletal Disorders Drugs Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 6.5% during 2025-2034. This report on global musculoskeletal disorders drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of ... Read More
-
Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), & Region - Global Forecast to 2030
... projected to reach USD 13.1 billion by 2030 from USD 7.1 billion in 2024, at a CAGR of 10.8% during the forecast period. The prefilled syringes market has had strong growth due to a number ... Read More
-
Global Log Management Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Global Rheumatoid Arthritis Diagnostic Devices Market 2024-2028
... 4.51% during the forecast period. The report on the rheumatoid arthritis diagnostic devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 ... Read More
-
Global Autoinjectors Market Size study & Forecast, by Application (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, and Others), Type (Disposable Autoinjectors and Reusable Autoinjectors), End User (Home Care Settings, Hospital and Clinics, and Others), and Regional Analysis, 2023-2030
... 2023-2030 Global Autoinjectors Market is valued approximately USD 8 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 16.05% over the forecast period 2023-2030. Autoinjectors are medical devices ... Read More
-
Injectable Cytotoxic Drugs Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 18.29 billion in 2023, and the market is now projected to grow from USD 19.03 billion in 2024 to USD 30.85 billion by 2032, exhibiting a CAGR of 6.2% during the forecast ... Read More
-
Global Rheumatoid Arthritis Drugs Market -2024-2031
... forecast period 2024-2031. Rheumatoid arthritis is a chronic inflammatory disorder that can affect more than just joints. In some people, the condition can damage a wide variety of body systems, including the skin, eyes, lungs, ... Read More
-
Autoimmune Drugs Market Size, Trends, Analysis, and Outlook By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Disease, Others), By Distribution Channel (Hospital, Pharmacy, Drug Store/Retail Pharmacy, Online), by Region, Country, Segment, and Companies, 2024-2030
... The global Autoimmune Drugs market size is poised to register 6.93% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Autoimmune Drugs ... Read More
-
Biologic Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Blood and Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Proteins, Cellular Therapies, Xenotransplantation Products), By Application (Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics), by Region, Country, Segment, and Companies, 2024-2030 The global Biologic Therapeutics market size is poised to register 7.8% growth (CAGR) from 2024 ... Read More
-
The 2025-2030 World Outlook for Anti-Arthritic Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Treatments
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Musculoskeletal Disorders
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Small Molecule Therapies for Rheumatoid Arthritis
... given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Pharmaceutical Therapeutics
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Rheumatology Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Drugs for Rheumatoid Arthritis
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Musculoskeletal Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Rheumatoid Arthritis Diagnostic Serology Tests
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
Research Assistance
